SCHEMBL4530992

SCHEMBL4530992

CC1(C)Cc2c(ccc(Cl)c2Cl)C(c2cnc3ccccc3c2)=N1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR2F2 P24468 1/20 0.39
PARP10 Q53GL7 1/20 0.39
PARP11 Q9NR21 1/20 0.39
AKR1C3 P42330 2/20 0.38
AKR1C2 P52895 2/20 0.38
TDP2 O95551 1/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PDGFRB P09619 3/20 0.37
PDGFRA P16234 3/20 0.37
BRD4 O60885 2/20 0.36
CREBBP Q92793 2/20 0.36
CYP2A6 P11509 1/20 0.36
NISCH Q9Y2I1 1/20 0.36
BIRC5 O15392 1/20 0.35
CYP1A2 P05177 1/20 0.35
PIK3CD O00329 1/20 0.34
PIK3CA P42336 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4400281 0.87 NR2F2 (0.40) NR2F2PARP10PARP11AKR1C3AKR1C2
SCHEMBL29919550 0.87 NR2F2 (0.40) NR2F2PARP10PARP11AKR1C3AKR1C2
SCHEMBL23265370 0.84 ALDH1A1 (0.36) MEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL4530771 0.83 TDP2 (0.41) NR2F2PARP10PARP11AKR1C3AKR1C2
SCHEMBL23265363 0.83 ABCB1 (0.34) AKR1C3AKR1C2MEN1ALDH1A1KMT2A
SCHEMBL4410968 0.82 AKR1C3 (0.45) NR2F2PARP10PARP11AKR1C3AKR1C2
SCHEMBL29919674 0.82 AKR1C3 (0.45) NR2F2PARP10PARP11AKR1C3AKR1C2
SCHEMBL4529985 0.81 BIRC5 (0.42) NR2F2PARP10PARP11AKR1C3AKR1C2
SCHEMBL4527597 0.81 ALDH1A1 (0.49) NR2F2PARP10PARP11AKR1C3AKR1C2
SCHEMBL4523639 0.81 NR2F2 (0.41) NR2F2PARP10PARP11AKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1736471-B1 3-(DIHYDRO(TETRAHYDRO)ISOQUINOLIN-1-YL)QUINOLINES MITSUI CHEMICALS AGRO INC (JP) 2014-01-08 EP disclosed
US-7632783-B2 fungicides, pesticides for protecting rice crop, tomatoes, cucumbers and green beans; 3-(5-fluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline MITSUI CHEMICALS AGRO, INC. (JP) 2009-12-15 US disclosed
US-20080275242-A1 3-(Dihydro(Tetrahydro)Isoquinolin-1-Yl)Quinoline Compound MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) 2008-11-06 US disclosed
EP-1736471-A1 3-(DIHYDRO(TETRAHYDRO)ISOQUINOLIN-1-YL)QUINOLINES Sankyo Agro Company, Limited (JP) 2006-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275242-A1 3-(Dihydro(Tetrahydro)Isoquinolin-1-Yl)Quinoline Compound QTRT1, RABL3, RECQL NR2F2 2146/4885PARP10 1935/4885PARP11 588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.